Physician

Michael Jules Castine, MD

According to 2025 Medicare claims, Michael Castine, MD (NPI: 1205814092) practices hematology/oncology in the Alexandria, LA market, with the plurality of this provider's patient population coming from Rapides, LA. This provider's primary affiliated billing organization is AMERICAN ONCOLOGY PARTNERS PA (NPI: 1265929723; TIN: 824681345) and primary practice location at 71301-8145. Castine is affiliated with the On Belay Health Solutions (ACO ID: A5260) and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Castine's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 577 traditional Medicare patients, billed 204,500 HCPCS/CPT codes, and received $4,174,337 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,352 prescription claims across 482 beneficiaries totaling $9,774,174 in drug costs, led by Revlimid (Lenalidomide). DME data shows 108 claims. Open Payments data shows 228 records totaling $329,079. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,486,981 to $4,174,337. Similarly, Part D prescription costs have moved sharply higher in recent years, from $1,567,176 to $9,774,174. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $6,475 and ending at $14,508.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	560	120,726	$1,486,981
2016	527	83,893	$1,534,339
2017	581	13,091	$250,750
2018	558	49,478	$693,122
2019	563	149,473	$2,452,578
2020	504	184,090	$3,148,439
2021	442	195,553	$3,474,772
2022	462	153,356	$2,819,544
2023	554	169,784	$3,068,013
2024	577	204,500	$4,174,337

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	315	2,434	$1,567,176
2016	366	3,057	$2,706,163
2017	364	3,083	$3,996,214
2018	367	2,924	$4,494,285
2019	374	2,979	$5,420,053
2020	361	2,657	$5,667,190
2021	364	2,859	$6,701,349
2022	389	2,780	$7,783,474
2023	388	3,043	$8,814,557
2024	482	3,352	$9,774,174

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	111	$32,116
2016	N/R	72	$20,769
2017	N/R	85	$10,847
2018	N/R	13	$295
2019	N/R	26	$4,293
2020	N/R	53	$4,143
2021	N/R	40	$1,647
2022	11	82	$3,022
2023	N/R	194	$19,200
2024	N/R	108	$4,601

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	320	772	$88
M0010	Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services	95	635	$72
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	176	205	$58
36415	Insertion of needle into vein for collection of blood sample	508	1,862	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	502	1,832	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	94	2,618	$1,486,899
Cabometyx	Cabozantinib S-Malate	36	1,068	$814,404
Jakafi	Ruxolitinib Phosphate	56	1,680	$770,425
Pomalyst	Pomalidomide	29	812	$659,281
Venclexta	Venetoclax	71	2,018	$436,294

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	38	$3,133
J8521	Capecitabine, oral, 500 mg	N	N/R	18	$684
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	24	$332
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	16	$301
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	12	$150

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	146	$3,262	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	82	$325,817	Novartis Pharmaceuticals Corporation
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Michael Jules Castine, MD?

Tedicare shows public-source Medicare data for Michael Jules Castine, MD (NPI 1205814092), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael Jules Castine, MD have ACO affiliation data?

Michael Jules Castine, MD is shown with ACO affiliation data for On Belay Health Solutions (MSSP, ACO ID A5260) and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Michael Jules Castine, MD?

Michael Jules Castine, MD is linked to AMERICAN ONCOLOGY PARTNERS PA (billing NPI 1265929723) in the available physician profile data.

Does Michael Jules Castine, MD have Open Payments data?

Michael Jules Castine, MD has 228 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.